HighVista Strategies LLC disclosed a new investment in Cidara Therapeutics (NASDAQ: CDTX) in a November 14, 2025 SEC filing, acquiring 70,904 shares valued at $6.79 million as of September 30, 2025. This stake represents 1.66% of the fund’s reportable U.S. equity assets for the quarter. The firm reported a total of 148 positions at that time. Following this filing, their top five holdings were highlighted.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
